Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substance abuse.

B Medoff-Cooper, T Verklan

    Naacog'S Clinical Issues in Perinatal and Women'S Health Nursing
    |January 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Prenatal substance abuse screening is crucial, as the placenta does not protect the fetus from developmental toxicity. This chapter reviews drugs, clinical impacts, and legal/ethical issues in prenatal care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Total Energy Expenditure of Infants with Congenital Heart Disease Who Have Undergone Surgical Intervention.

    Pediatric cardiology·2015
    Same author

    Pediatric care for preterm infants after NICU discharge: high number of office visits and prescription medications.

    Journal of perinatology : official journal of the California Perinatal Association·2008
    Same author

    A non-theorist's perspective on nursing theory: issues of the 1990s.

    Scholarly inquiry for nursing practice·2002
    Same author

    Multi-system approach to the assessment of successful feeding.

    Acta paediatrica (Oslo, Norway : 1992)·2000
    Same author

    Nutritive sucking and neurobehavioral development in preterm infants from 34 weeks PCA to term.

    MCN. The American journal of maternal child nursing·2000
    Same author

    Accelerated discharge of low birth weight infants from neonatal intensive care: a randomized, controlled trial. The Early Discharge Study Group.

    Journal of perinatology : official journal of the California Perinatal Association·1999
    Same journal

    Creating brave new families with advanced reproductive technologies.

    NAACOG's clinical issues in perinatal and women's health nursing·1992
    Same journal

    Understanding the ethical issues in infertility nursing practice.

    NAACOG's clinical issues in perinatal and women's health nursing·1992
    Same journal

    Redefining the concepts of success and failure in infertility treatment.

    NAACOG's clinical issues in perinatal and women's health nursing·1992
    Same journal

    The nursing role in assisted reproductive technologies.

    NAACOG's clinical issues in perinatal and women's health nursing·1992
    Same journal

    Recent advances in the treatment of male infertility.

    NAACOG's clinical issues in perinatal and women's health nursing·1992
    Same journal

    Integration of clinical genetics into assisted reproductive technologies: implications for nursing practice.

    NAACOG's clinical issues in perinatal and women's health nursing·1992
    See all related articles

    Area of Science:

    • Toxicology
    • Obstetrics
    • Public Health

    Background:

    • The thalidomide tragedy highlighted risks of in-utero chemical exposure.
    • The placenta does not act as a protective barrier for the developing fetus.

    Purpose of the Study:

    • To examine the role of substance abuse screening in prenatal care.
    • To discuss the clinical implications of various substances used by pregnant women.
    • To address legal and ethical considerations in prenatal substance abuse.

    Main Methods:

    • Review of legal and illegal substances with potential for developmental toxicity.
    • Discussion of physiological and care-related issues.
    • Examination of legal and ethical frameworks.

    Related Experiment Videos

    Main Results:

    • Identifies common legal substances (artificial sweeteners, caffeine, tobacco, alcohol, OTC/prescription drugs) and illegal substances (marijuana, phencyclidine, LSD, opiates, cocaine) abused during pregnancy.
    • Highlights clinical implications and risks associated with prenatal substance exposure.
    • Addresses the necessity of comprehensive screening and management strategies.

    Conclusions:

    • Substance abuse screening is essential in prenatal care to mitigate developmental toxicity risks.
    • A thorough understanding of abused substances and their effects is critical for patient management.
    • Legal and ethical considerations must guide prenatal care for substance-abusing pregnant individuals.